Aspire Biopharma signs LOI to acquire Driver Controls Systems unit for $30M

Aspire Biopharma Holdings, Inc.

Entered non-binding LOI to acquire Driver Controls Systems business unit of Firefish Topco for $30M cash-free, debt-free.
Purchase price payable in cash at closing; no new equity raise anticipated.
Break-up fees of $3.5M applicable under certain circumstances; 30-day no-shop period.
Company plans to engage Lakewood & Company for management services post-closing.
Acquisition subject to definitive agreement; LOI non-binding except for exclusivity, confidentiality, and break-up fees.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Aspire Biopharma Holdings, Inc. entered into LOI with Firefish Topco, LLC valued at $30.0 million (effective 2026-04-15).

Action: entry
Counterparty: Firefish Topco, LLC
Value: $30.0 million
Effective: 2026-04-15

Exact text from the filing

On April 15, 2026, Aspire Biopharma Holdings, Inc., a Delaware corporation (the “Company” or “Purchaser”) announced that it has entered into a non-binding letter of intent (the “LOI”) for the acquisition (as described below, the “Acquisition”) of 100% of the Driver Controls Systems business unit ( “DCS” ) of Firefish Topco, LLC

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

Aspire Biopharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-016683

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.